Austin Health

Title
Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension.
Publication Date
2000-03-01
Author(s)
Burrell, Louise M
Risvanis, John
Johnston, Colin I
Naitoh, M
Balding, Leanne C
Type of document
Journal Article
Abstract
The precise role of vasopressin in the pathophysiology of cardiovascular disease is controversial, but this peptide hormone is important for several reasons. Firstly, circulating concentrations of vasopressin are elevated in heart failure and some forms of hypertension. Secondly, there is evidence that vasopressin is synthesized not only in the hypophysial-pituitary axis but also in peripheral tissues including the heart where it acts as a paracrine hormone. Thirdly, vasopressin has vasoconstrictor, mitogenic, hyperplastic and renal fluid retaining properties which, by analogy with angiotensin II, may have deleterious effects when present in chronic excess. Finally, the availability of orally active non-peptide vasopressin receptor antagonists allows vasopressin receptor antagonism to be considered as a therapeutic option in cardiovascular disease.
Link
Citation
Experimental Physiology; 85 Spec No(): 259S-265S
Jornal Title
Experimental physiology

Files:

NameSizeformatDescriptionLink